×
About 1,165 results

ALLMedicine™ Soft Tissue Tumors Center

Research & Reviews  440 results

Lipofibromatosis: Central Nervous System Involvement by a Benign Neoplasm.
https://doi.org/10.1080/15513815.2022.2071509
Fetal and Pediatric Pathology; Rebolledo A, Guerra LJ et. al.

May 11th, 2022 - Background: Lipofibromatosis is a relatively new entity, considered in the differential diagnosis of soft tissue tumors in children, involving mainly the extremities. Most cases can be completely resected without recurrence. Atypical forms have be...

Benign and Malignant Soft-Tissue Tumors Workup
https://emedicine.medscape.com/article/1253816-workup

Apr 28th, 2022 - Laboratory Studies Other than histologic and cytogenetic analysis, no specific laboratory tests exist for diagnosing soft-tissue tumors. However, ancillary studies may be indicated as part of the general workup in patients with other systemic cond...

Diagnostic accuracy of fine needle aspiration cytology and core needle biopsy in bone a...
https://doi.org/10.1016/j.anndiagpath.2022.151936
Annals of Diagnostic Pathology; Ariizumi T, Kawashima H et. al.

Apr 16th, 2022 - Fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) can provide tissue samples for the diagnoses of bone and soft tissue tumors. We evaluated the diagnostic accuracy of FNAC and CNB, the usefulness of the image-guided needle proced...

Diagnostic Performance of Dynamic Contrast-Enhanced MRI and 18F-FDG PET/CT for Evaluati...
https://doi.org/10.1016/j.acra.2022.03.009
Academic Radiology; Zhang Y, Zhao H et. al.

Apr 10th, 2022 - To assess the diagnostic performance of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and fluorine-18-fluorodeoxyglucose (18F-FDG) positron-emission tomography/computed tomography (PET/CT) parameters in evaluating the biological...

Diagnostic delay in soft tissue tumors: a single-center study of a university cancer ce...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988367
BMC Health Services Research; Ballhause TM, Reiter A et. al.

Apr 8th, 2022 - Lumps and soft tissue tumors (STT) are frequent reasons for consulting a physician. Most STT are benign, and lumps are not always associated with a tumor. MRI is the most advanced imaging modality to assist a provisional diagnosis of STT. Only a s...

see more →

Clinicaltrials.gov  7 results

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule
https://clinicaltrials.gov/ct2/show/NCT04223583

Mar 16th, 2022 - Soft tissue sarcoma STS is a group of malignant tumors derived from connective tissue other than bone and cartilage. It can occur in any part of the body at any age, and there is no significant gender difference.According to pathological classific...

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors
https://clinicaltrials.gov/ct2/show/NCT04377360

Feb 18th, 2022 - Diffusing Alpha-emitter Radiation Therapy is a form of interstitial brachytherapy which may be effective in treating malignant skin and superficial soft tissue tumors for several reasons. First, alpha-emitting radionuclides have a high linear ener...

Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
https://clinicaltrials.gov/ct2/show/NCT05199376

Jan 20th, 2022 - Neurofibromatosis type 1 (NF1) is an autosomal dominant disease affecting chromosome 17. It is manifested by a neurogenic tumor proliferation that forms cutaneous, subcutaneous or deep neurofibromas. Neurofibromas can cause functional discomfort, ...

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
https://clinicaltrials.gov/ct2/show/NCT03785964

Dec 15th, 2021 - Desmoid tumors, also referred to as aggressive fibromatosis, are rare, locally invasive, slow growing soft tissue tumors. Although considered benign because of their inability to metastasize, desmoid tumors can cause significant morbidity and occa...

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
https://clinicaltrials.gov/ct2/show/NCT02677961

Oct 22nd, 2020 - Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is th...

see more →

News  13 results

Disease State: Advanced Soft Tissue Sarcoma
https://www.onclive.com/view/disease-state-advanced-soft-tissue-sarcoma

Apr 2nd, 2021 - Transcript:Mark Agulnik, MD: Soft tissue sarcomas are considered to be rare tumors. The interesting thing is when you go see a sarcoma specialist—this is what they do every day—and so the rarity of it is not really rare for them. That’s the ...

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas
https://www.onclive.com/view/novel-molecular-targets-for-drug-development-in-non-gist-sarcomas

Dec 20th, 2020 - William D. Tap, MD Abstract The characterization of molecular abnormalities implicated in the tumorigenesis of sarcomas is being increasingly applied to the classification, prognostication and, in particular situations, management of these ...

Rucaparib Prostate Cancer Approval Sets Stage for Further Research
https://www.onclive.com/view/rucaparib-prostate-cancer-approval-sets-stage-for-further-research

Dec 20th, 2020 - The FDA approval of rucaparib (Rubraca) in BRCA-mutant metastatic castration-resistant prostate cancer (mCRPC) marks the first designation for a biomarker-driven targeted therapy in the field, said Alan H. Bryce, MD, who added that the regulatory ...

My Strangest Case: A Woman With Varicose Veins and Leg Pain
https://reference.medscape.com/viewarticle/936414_2

Sep 2nd, 2020 - Discussion To review, our patient was a 60-year-old woman with a large soft tissue mass that involved both the anterior and posterior compartments of the left knee, with extensive extra-articular extension and osseous erosions present. Her differe...

Primary Cardiac Sarcoma: An Analysis of the National Cancer Database (NCDB)
https://www.mdedge.com/fedprac/avaho/article/207680/mixed-topics/primary-cardiac-sarcoma-analysis-national-cancer-database?channel=53
Vardell VA, Abushalha K et. al.

Sep 6th, 2019 - Introduction: Primary Cardiac Sarcomas (PCS) are exceptionally rare malignancies, representing approximately 25% of all malignant primary cardiac tumors. Due to the rarity of these neoplasms, literature on the characteristics, optimal management,.

see more →

Patient Education  6 results see all →